Clarius Group LLC’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$970K Buy
8,753
+445
+5% +$49.3K 0.06% 151
2025
Q1
$931K Buy
8,308
+1,460
+21% +$164K 0.06% 151
2024
Q4
$633K Sell
6,848
-175
-2% -$16.2K 0.04% 180
2024
Q3
$587K Sell
7,023
-278
-4% -$23.2K 0.04% 194
2024
Q2
$501K Sell
7,301
-221
-3% -$15.2K 0.04% 214
2024
Q1
$551K Sell
7,522
-2,319
-24% -$170K 0.04% 208
2023
Q4
$797K Buy
9,841
+360
+4% +$29.2K 0.07% 156
2023
Q3
$710K Sell
9,481
-3,559
-27% -$267K 0.07% 160
2023
Q2
$1.01M Buy
13,040
+34
+0.3% +$2.62K 0.08% 141
2023
Q1
$1.08M Buy
13,006
+1,098
+9% +$91.1K 0.09% 121
2022
Q4
$1.02M Buy
11,908
+923
+8% +$79.2K 0.09% 132
2022
Q3
$678K Buy
10,985
+4,664
+74% +$288K 0.07% 168
2022
Q2
$391K Sell
6,321
-4,074
-39% -$252K 0.04% 264
2022
Q1
$755K Hold
10,395
0.06% 172
2021
Q4
$755K Buy
10,395
+747
+8% +$54.3K 0.06% 172
2021
Q3
$674K Buy
9,648
+344
+4% +$24K 0.06% 169
2021
Q2
$641K Buy
9,304
+20
+0.2% +$1.38K 0.06% 174
2021
Q1
$600K Buy
9,284
+3,573
+63% +$231K 0.06% 161
2020
Q4
$333K Sell
5,711
-918
-14% -$53.5K 0.04% 240
2020
Q3
$419K Sell
6,629
-4,162
-39% -$263K 0.05% 164
2020
Q2
$830K Buy
10,791
+1,538
+17% +$118K 0.12% 94
2020
Q1
$692K Buy
9,253
+1,171
+14% +$87.6K 0.13% 89
2019
Q4
$518K Buy
8,082
+572
+8% +$36.7K 0.08% 123
2019
Q3
$476K Buy
7,510
+1,140
+18% +$72.3K 0.09% 124
2019
Q2
$430K Buy
6,370
+1,234
+24% +$83.3K 0.09% 122
2019
Q1
$334K Buy
5,136
+1,703
+50% +$111K 0.08% 130
2018
Q4
$215K Buy
+3,433
New +$215K 0.08% 112
2016
Q2
Sell
-2,505
Closed -$230K 86
2016
Q1
$230K Sell
2,505
-141
-5% -$12.9K 0.13% 73
2015
Q4
$267K Buy
+2,646
New +$267K 0.15% 57